{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:12:04Z","timestamp":1791465124983,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Zhejiang Medical Health Science and technology Program","award":["2019RC204"],"award-info":[{"award-number":["2019RC204"]}]},{"name":"Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province","award":["2022E10022"],"award-info":[{"award-number":["2022E10022"]}]},{"name":"the Competitive Research Project of Quzhou Science & Technology Bureau","award":["2023K110"],"award-info":[{"award-number":["2023K110"]}]},{"name":"Wenzhou Science and Technology Planning Project","award":["2023Y2064"],"award-info":[{"award-number":["2023Y2064"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s10549-025-07623-8","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T14:15:23Z","timestamp":1739542523000},"page":"71-89","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Formosanin C inhibits triple-negative breast cancer progression by suppressing the phosphorylation of STAT3 and the polarization of M2 macrophages"],"prefix":"10.1007","volume":"211","author":[{"given":"Yin-Wei","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Xuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Dong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Xi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Qiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-Zhi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Xia","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan-Xuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"24","key":"7623_CR1","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1200\/JCO.2010.32.5936","volume":"29","author":"DA Berry","year":"2011","unstructured":"Berry DA, Ueno NT, Johnson MM, Lei X, Caputo J, Smith DA, Yancey LJ, Crump M, Stadtmauer EA, Biron P et al (2011) High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials. J Clin Oncol: Off J Am Soc Clin Oncol 29(24):3224\u20133231","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"issue":"1","key":"7623_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1200\/JCO.2014.57.0572","volume":"33","author":"WM Sikov","year":"2015","unstructured":"Sikov WM, Berry DA, Perou CM, Singh B, Cirrincione CT, Tolaney SM, Kuzma CS, Pluard TJ, Somlo G, Port ER et al (2015) Impact of the addition of carboplatin and\/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance). J Clin Oncol: Off J Am Soc Clin Oncol 33(1):13\u201321","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"issue":"13","key":"7623_CR3","doi-asserted-by":"publisher","first-page":"e625","DOI":"10.1016\/S1470-2045(14)70364-X","volume":"15","author":"AM Brewster","year":"2014","unstructured":"Brewster AM, Chavez-MacGregor M, Brown P (2014) Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry. Lancet Oncol 15(13):e625\u2013e634","journal-title":"Lancet Oncol"},{"issue":"4","key":"7623_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41419-019-1513-5","volume":"10","author":"VY Shin","year":"2019","unstructured":"Shin VY, Chen J, Cheuk IW, Siu MT, Ho CW, Wang X, Jin H, Kwong A (2019) Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness. Cell Death Dis 10(4):270","journal-title":"Cell Death Dis"},{"issue":"15 Pt 1","key":"7623_CR5","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res: An Off J Am Assoc Cancer Res 13(15 Pt 1):4429\u20134434","journal-title":"Clin Cancer Res: An Off J Am Assoc Cancer Res"},{"issue":"36","key":"7623_CR6","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1200\/JCO.2006.06.5664","volume":"24","author":"BG Haffty","year":"2006","unstructured":"Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, Harris L, Hait W, Toppmeyer D (2006) Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol: Off J Am Soc Clin Oncol 24(36):5652\u20135657","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"issue":"7","key":"7623_CR7","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Investig 121(7):2750\u20132767","journal-title":"J Clin Investig"},{"issue":"4","key":"7623_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1158\/2326-6066.CIR-13-0127","volume":"2","author":"EA Mittendorf","year":"2014","unstructured":"Mittendorf EA, Philips AV, Meric-Bernstam F, Qiao N, Wu Y, Harrington S, Su X, Wang Y, Gonzalez-Angulo AM, Akcakanat A et al (2014) PD-L1 expression in triple-negative breast cancer. Cancer Immunol Res 2(4):361\u2013370","journal-title":"Cancer Immunol Res"},{"issue":"8","key":"7623_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrd4088","volume":"12","author":"G Miklossy","year":"2013","unstructured":"Miklossy G, Hilliard TS, Turkson J (2013) Therapeutic modulators of STAT signalling for human diseases. Nat Rev Drug Discovery 12(8):611\u2013629","journal-title":"Nat Rev Drug Discovery"},{"issue":"13","key":"7623_CR10","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.7150\/thno.41498","volume":"10","author":"L Tong","year":"2020","unstructured":"Tong L, Li J, Li Q, Wang X, Medikonda R, Zhao T, Li T, Ma H, Yi L, Liu P et al (2020) ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. Theranostics 10(13):5943\u20135956","journal-title":"Theranostics"},{"issue":"52","key":"7623_CR11","doi-asserted-by":"publisher","first-page":"20852","DOI":"10.1073\/pnas.0810958105","volume":"105","author":"M Marzec","year":"2008","unstructured":"Marzec M, Zhang Q, Goradia A, Raghunath PN, Liu X, Paessler M, Wang HY, Wysocka M, Cheng M, Ruggeri BA, Wasik MA (2008) Oncogenic kinase NPM\/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7\u2013H1). Proc Natl Acad Sci USA 105(52):20852\u201320857","journal-title":"Proc Natl Acad Sci USA"},{"key":"7623_CR12","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2022.5440","author":"Z Meng","year":"2022","unstructured":"Meng Z, Zhang R, Wu X, Zhang M, Jin T (2022) PD-L1 mediates triple-negative breast cancer evolution via the regulation of TAM\/M2 polarization. Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2022.5440","journal-title":"Int J Oncol"},{"issue":"33","key":"7623_CR13","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1038\/onc.2009.180","volume":"28","author":"NJ Sullivan","year":"2009","unstructured":"Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, Oberyszyn TM, Hall BM (2009) Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 28(33):2940\u20132947","journal-title":"Oncogene"},{"issue":"5","key":"7623_CR14","first-page":"1475","volume":"12","author":"HC Chiang","year":"1992","unstructured":"Chiang HC, Wang JJ, Wu RT (1992) Immunomodulating effects of the hydrolysis products of formosanin C and beta-ecdysone from Paris formosana Hayata. Anticancer Res 12(5):1475\u20131478","journal-title":"Anticancer Res"},{"issue":"7","key":"7623_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/0192-0561(90)90042-L","volume":"12","author":"RT Wu","year":"1990","unstructured":"Wu RT, Chiang HC, Fu WC, Chien KY, Chung YM, Horng LY (1990) Formosanin-C, an immunomodulator with antitumor activity. Int J Immunopharmacol 12(7):777\u2013786","journal-title":"Int J Immunopharmacol"},{"key":"7623_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.cbi.2014.06.023","volume":"220","author":"Y Li","year":"2014","unstructured":"Li Y, Man S, Li J, Chai H, Fan W, Liu Z, Gao W (2014) The antitumor effect of formosanin C on HepG2 cell as revealed by 1H-NMR based metabolic profiling. Chem Biol Interact 220:193\u2013199","journal-title":"Chem Biol Interact"},{"issue":"2","key":"7623_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/antiox11020298","volume":"11","author":"HC Chen","year":"2022","unstructured":"Chen HC, Tang HH, Hsu WH, Wu SY, Cheng WH, Wang BY, Su CL (2022) Vulnerability of triple-negative breast cancer to Saponin Formosanin C-Induced Ferroptosis. Antioxidants (Basel) 11(2):298","journal-title":"Antioxidants (Basel)"},{"key":"7623_CR18","doi-asserted-by":"publisher","first-page":"1076958","DOI":"10.3389\/fphar.2022.1076958","volume":"13","author":"J Lu","year":"2022","unstructured":"Lu J, Xu F, Rao C, Shen C, Jin J, Zhu Z, Wang C, Li Q (2022) Mechanism of action of paclitaxel for treating glioblastoma based on single-cell RNA sequencing data and network pharmacology. Front Pharmacol 13:1076958","journal-title":"Front Pharmacol"},{"issue":"2","key":"7623_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461","journal-title":"J Comput Chem"},{"issue":"12","key":"7623_CR20","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1681\/ASN.2016060603","volume":"27","author":"JS Duffield","year":"2016","unstructured":"Duffield JS (2016) Beyond EMT: Epithelial STAT3 as a central regulator of fibrogenesis. J Am Soc Nephrol 27(12):3502\u20133504","journal-title":"J Am Soc Nephrol"},{"key":"7623_CR21","doi-asserted-by":"publisher","first-page":"154618","DOI":"10.1016\/j.phymed.2022.154618","volume":"109","author":"J Li","year":"2023","unstructured":"Li J, Wu Z, Chen G, Wang X, Zhu X, Zhang Y, Zhang R, Wu W, Zhu Y, Ma L, Yu H (2023) Formosanin C inhibits non-small-cell lung cancer progression by blocking MCT4\/CD147-mediated lactate export. Phytomedicine 109:154618","journal-title":"Phytomedicine"},{"issue":"5","key":"7623_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/kjm2.12658","volume":"39","author":"ML Chu","year":"2023","unstructured":"Chu ML, Lin PW, Liu YW, Wu SY, Lan SH, Su CL, Liu HS (2023) Formosanin C suppresses cancer cell proliferation and migration by impeding autophagy machinery. Kaohsiung J Med Sci 39(5):489\u2013500","journal-title":"Kaohsiung J Med Sci"},{"issue":"8","key":"7623_CR23","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/antiox9080682","volume":"9","author":"PL Lin","year":"2020","unstructured":"Lin PL, Tang HH, Wu SY, Shaw NS, Su CL (2020) Saponin Formosanin C-induced ferritinophagy and ferroptosis in human hepatocellular carcinoma cells. Antioxidants (Basel) 9(8):682","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"7623_CR24","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3892\/mmr.2014.2728","volume":"11","author":"L Fan","year":"2015","unstructured":"Fan L, Li Y, Sun Y, Yue Z, Meng J, Zhang X, Zhang R, Zhang D, Zhang F, Mei Q (2015) Paris saponin VII inhibits metastasis by modulating matrix metalloproteinases in colorectal cancer cells. Mol Med Rep 11(1):705\u2013711","journal-title":"Mol Med Rep"},{"issue":"5","key":"7623_CR25","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.3892\/or.2015.3836","volume":"33","author":"M Yang","year":"2015","unstructured":"Yang M, Zou J, Zhu H, Liu S, Wang H, Bai P, Xiao X (2015) Paris saponin II inhibits human ovarian cancer cell-induced angiogenesis by modulating NF-\u03baB signaling. Oncol Rep 33(5):2190\u20132198","journal-title":"Oncol Rep"},{"key":"7623_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.phrs.2018.11.029","volume":"139","author":"M Chen","year":"2019","unstructured":"Chen M, Ye K, Zhang B, Xin Q, Li P, Kong AN, Wen X, Yang J (2019) Paris Saponin II inhibits colorectal carcinogenesis by regulating mitochondrial fission and NF-\u03baB pathway. Pharmacol Res 139:273\u2013285","journal-title":"Pharmacol Res"},{"key":"7623_CR27","doi-asserted-by":"publisher","first-page":"115206","DOI":"10.1016\/j.taap.2020.115206","volume":"406","author":"S Man","year":"2020","unstructured":"Man S, Lv P, Cui J, Liu F, Peng L, Ma L, Liu C, Gao W (2020) Paris saponin II-induced paraptosis-associated cell death increased the sensitivity of cisplatin. Toxicol Appl Pharmacol 406:115206","journal-title":"Toxicol Appl Pharmacol"},{"issue":"7","key":"7623_CR28","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1172\/JCI44745","volume":"121","author":"LL Marotta","year":"2011","unstructured":"Marotta LL, Almendro V, Marusyk A, Shipitsin M, Schemme J, Walker SR, Bloushtain-Qimron N, Kim JJ, Choudhury SA, Maruyama R et al (2011) The JAK2\/STAT3 signaling pathway is required for growth of CD44\u207aCD24\u207b stem cell-like breast cancer cells in human tumors. J Clin Investig 121(7):2723\u20132735","journal-title":"J Clin Investig"},{"issue":"7","key":"7623_CR29","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1593\/neo.13706","volume":"15","author":"Q Chang","year":"2013","unstructured":"Chang Q, Bournazou E, Sansone P, Berishaj M, Gao SP, Daly L, Wels J, Theilen T, Granitto S, Zhang X et al (2013) The IL-6\/JAK\/Stat3 feed-forward loop drives tumorigenesis and metastasis. Neoplasia 15(7):848\u2013862","journal-title":"Neoplasia"},{"issue":"1","key":"7623_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13046-019-1206-z","volume":"38","author":"JJ Qin","year":"2019","unstructured":"Qin JJ, Yan L, Zhang J, Zhang WD (2019) STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review. J Exp Clin Cancer Res: CR 38(1):195","journal-title":"J Exp Clin Cancer Res: CR"},{"issue":"5","key":"7623_CR31","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1002\/hep.32023","volume":"74","author":"L Torrens","year":"2021","unstructured":"Torrens L, Montironi C, Puigveh\u00ed M, Mesropian A, Leslie J, Haber PK, Maeda M, Balaseviciute U, Willoughby CE, Abril-Fornaguera J et al (2021) Immunomodulatory effects of lenvatinib plus anti-programmed cell death protein 1 in mice and rationale for patient enrichment in hepatocellular Carcinoma. Hepatology (Baltimore, MD) 74(5):2652\u20132669","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"3","key":"7623_CR32","doi-asserted-by":"publisher","first-page":"e1291106","DOI":"10.1080\/2162402X.2017.1291106","volume":"6","author":"C Lu","year":"2017","unstructured":"Lu C, Talukder A, Savage NM, Singh N, Liu K (2017) JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer. Oncoimmunology 6(3):e1291106","journal-title":"Oncoimmunology"},{"issue":"12","key":"7623_CR33","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1111\/j.1349-7006.2007.00633.x","volume":"98","author":"YN Kimura","year":"2007","unstructured":"Kimura YN, Watari K, Fotovati A, Hosoi F, Yasumoto K, Izumi H, Kohno K, Umezawa K, Iguchi H, Shirouzu K et al (2007) Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis. Cancer Sci 98(12):2009\u20132018","journal-title":"Cancer Sci"},{"issue":"2","key":"7623_CR34","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1158\/1078-0432.CCR-16-1163","volume":"23","author":"AM Seifert","year":"2017","unstructured":"Seifert AM, Zeng S, Zhang JQ, Kim TS, Cohen NA, Beckman MJ, Medina BD, Maltbaek JH, Loo JK, Crawley MH et al (2017) PD-1\/PD-L1 blockade enhances T-cell activity and antitumor efficacy of imatinib in gastrointestinal stromal tumors. Clin Cancer Res: An off J the Am Assoc Cancer Res 23(2):454\u2013465","journal-title":"Clin Cancer Res: An off J the Am Assoc Cancer Res"},{"issue":"3","key":"7623_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s13238-013-2084-3","volume":"4","author":"Y Fan","year":"2013","unstructured":"Fan Y, Mao R, Yang J (2013) NF-\u03baB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell 4(3):176\u2013185","journal-title":"Protein Cell"},{"key":"7623_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.canlet.2019.10.013","volume":"468","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Zhan H (2020) Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion. Cancer Lett 468:72\u201381","journal-title":"Cancer Lett"},{"issue":"5","key":"7623_CR37","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3390\/nu13051718","volume":"13","author":"SS Messeha","year":"2021","unstructured":"Messeha SS, Zarmouh NO, Soliman KFA (2021) Polyphenols modulating effects of PD-L1\/PD-1 checkpoint and EMT-mediated PD-L1 overexpression in breast cancer. Nutrients 13(5):1718","journal-title":"Nutrients"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07623-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07623-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07623-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:01:17Z","timestamp":1765353677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07623-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["7623"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07623-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"7 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Funding note has been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declared no potential conflicts of interest with respect to the research, author-ship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal studies were conducted in accordance with the Wenzhou Medical University\u2019s Policy on the Care and Use of Laboratory Animals. The protocols for these studies were approved by the Animal Policy and Welfare Committee of Wenzhou Medical College.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}